Print

AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2013 Financial And Operating Results  
3/21/2014 9:22:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

//-->